EU Probes Novo Nordisk Drugs After Reports of Suicidal Thoughts
Insurance Journal - Jul 10, 2023
The European Medicines Agency (EMA) is probing Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients on the drugs thinking about suicide or self-harm. Shares of the Danish drugmaker fell about …...
Recommended Articles
Posted: Apr 16, 2026
The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...
Posted: Apr 16, 2026
Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...
Posted: Apr 16, 2026
Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...